Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Pfizer has re-entered the obesity drug sector by acquiring Metsera, Inc., having successfully outmaneuvered six other bidders ...

The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.

Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the ...

Women sue Pfizer, claiming the contraceptive Depo-Provera caused brain tumors; over 1,300 lawsuits are being consolidated, ...

Of the three highest bidders, Pfizer’s purchase proposal for Metsera was the lowest, regulatory documents reveal. The New ...

Depo-Provera is one of many birth control options for women. The injectable drug was approved by the FDA in 1992; since then, it’s been a popular alternative, especially for Black women, who are ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also ...

Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock ...

Down-to-the wire team negotiations capped a long dance between President Trump and CEO Albert Bourla.

Pfizer CEO Albert Bourla, who was in the Oval Office with the president for the announcement, said Mr. Trump's threat of 100% ...